Merck’s next-gen HPV vaccine looks good in PhIII, but sales may disappoint

John Carroll Merck believes it can win near-term approval for a new HPV vaccine that will do better than Gardasil in guarding women against the virus that causes cervical cancer. But ...

Flailing Ariad swallows poison pill to fend off takeovers

Damian Garde With a plummeting share price and grim prospects for its lead drug, Ariad Pharmaceuticals is adopting a shareholder rights plan to deter would-be corporate raiders, a move ...

StemCells, Inc. Acquires Seminal Neural Stem Cell Patent Portfolio

barbara.lempert NEWARK, Calif., Oct. 29, 2013 (GLOBE NEWSWIRE) — StemCells, Inc. (Nasdaq:STEM) today announced the acquisition of a portfolio of issued US and Canadian patents ...

Neovasc Inc. Announces Publication of Positive Tiara Preclinical Data in the Journal JACC: Cardiovascular Interventions

barbara.lempert -Preclinical Studies Show Innovative Transcatheter Product to Treat Mitral Regurgitation is Safe, Technically Feasible and Results in a Well-Functioning Mitral Bioprosthesis- ...

ImmunoGen 1Q FY2014 Revenue Up

mia.burns ImmunoGen, Inc. Reports First Quarter Fiscal Year 2014 Financial Results and Provides Quarterly Update Quarterly Conference Call Today at 8:00 am ET− WALTHAM, Mass.–(BUSINESS ...

Humira sales, up 19%, continue to carry AbbVie

Eric Palmer What is better than having the best-selling drug in the world.? Having the best-selling drug and seeing its sales sprint ahead by more than 19% for a quarter. FiercePharma ...

Atheris and Debiopharm Group to collaborate

barbara.lempert Atheris and Debiopharm Group™ to collaborate for the lead optimization of Debio 0826 using a “Reverse-Discovery” strategy Geneva and Lausanne, Switzerland – ...

Armed-antibody successes inspire a burst of new building projects, industry deals

John Carroll The rapid success of Roche's breast cancer drug Kadcyla following the breakthrough approval of Seattle Genetics' Adcetris helped make antibody-drug conjugates one ...

Versant Ventures amassing $200M fund for biotech upstarts

Damian Garde California VC Versant Ventures is putting together another $ 200 million fund, according to a regulatory filing, building up its chest as biotech investments maintain ...

Ex-Bristol-Myers exec faces 1 year in prison for insider trading

Tracy Staton A former Bristol-Myers Squibb executive could have walked out of a courtroom yesterday facing more than three years in prison for insider trading. But he was sentenced ...

Amarin slashes staff by half

Eric Palmer Amarin couldn't wait for the FDA's final decision on whether to grant its fish oil drug Vascepa approval for a wider use. With the handwriting on the wall, ...

FDA Approves Opsumit for PAH

mia.burns Actelion receives US FDA approval of Opsumit (macitentan) for the treatment of pulmonary arterial hypertension ALLSCHWIL, SWITZERLAND – 18 OCTOBER 2013 – ...
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS